{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:20Z","timestamp":1781636060231,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The course of disease development during the coronavirus disease 2019\n                      <jats:bold>(<\/jats:bold>\n                      COVID-19) pandemic has demonstrated a very wide spectrum, with the most vulnerable group of severe disease comprising\u2009&gt;\u200910% of cases worldwide. Previously, several clinical and laboratory phenotypes have been suggested for the prediction of severe disease courses with different impacts in diverse populations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a logistic regression model, we performed a study of 227 patients (37% with severe disease), all of whom were ethnically Uzbek, to identify predisease clinical phenotypes associated with disease severity, such as type 2 diabetes (T2D), obesity, hypertension and ischaemic heart disease (IHD), and ascertained the contribution of the angiotensin converting enzyme-encoding gene insertion\/deletion (ACE I\/D) rs1799752 and the interleukin-28 isoform B (IL28B) gene rs12979860 genetic markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that the greatest contribution to the severe disease group from IHD was observed before the start of infection, whereas the contributions of T2D and obesity were only nominally important for the model. Interestingly, the ACE rs1799752 DD genotype together with clinical phenotypes contributed to the discrimination of the severe disease group, but we detected no effect of the IL28B polymorphism. However, without the inclusion of clinical phenotypes in the model, we did not observe a significant ACE polymorphism association with COVID-19 severity (likelihood ratio test\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.1). We critically reviewed allelic frequencies for ACE rs1799752 in different populations and studies in an attempt to explain possible discrepancies in previously reported associations in diverse populations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a modest group of patients from the Uzbek population, we confirmed the importance of IHD, metabolic disorders and ACE genetics in the development of severe COVID-19 infection in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12798-6","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:35:33Z","timestamp":1770903333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ischaemic heart disease is the factor associated with severe COVID-19 in the urban population of Uzbekistan: a single\u2011center retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Nargiz","family":"Ibadullaeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkin","family":"Musabaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziza","family":"Khikmatullaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Padyukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"6","key":"12798_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov PV, Ghafari M, Beer M, et al. The evolution of SARS-CoV-2. Nat Rev Microbiol. 2023;21(6):361\u201379. https:\/\/doi.org\/10.1038\/s41579-023-00878-2.","journal-title":"Nat Rev Microbiol"},{"issue":"7816","key":"12798_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","volume":"583","author":"X Zhang","year":"2020","unstructured":"Zhang X, Tan Y, Ling Y, et al. Viral and host factors related to the clinical outcome of COVID-19. Nature. 2020;583(7816):437\u201340. https:\/\/doi.org\/10.1038\/s41586-020-2355-0.","journal-title":"Nature"},{"key":"12798_CR3","doi-asserted-by":"publisher","unstructured":"Zsichla L, Muller V. Risk factors of severe COVID-19: a review of host, viral and environmental factors. Viruses. 2023;15(1). https:\/\/doi.org\/10.3390\/v15010175.","DOI":"10.3390\/v15010175"},{"issue":"16","key":"12798_CR4","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1007\/s00018-021-03889-5","volume":"78","author":"S Boutin","year":"2021","unstructured":"Boutin S, Hildebrand D, Boulant S, et al. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs. Cell Mol Life Sci. 2021;78(16):5953\u201376. https:\/\/doi.org\/10.1007\/s00018-021-03889-5.","journal-title":"Cell Mol Life Sci"},{"issue":"7962","key":"12798_CR5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41586-023-06034-3","volume":"617","author":"E Pairo-Castineira","year":"2023","unstructured":"Pairo-Castineira E, Rawlik K, Bretherick AD, et al. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature. 2023;617(7962):764\u20138. https:\/\/doi.org\/10.1038\/s41586-023-06034-3.","journal-title":"Nature"},{"key":"12798_CR6","doi-asserted-by":"publisher","unstructured":"Vardavas CI, Mathioudakis AG, Nikitara K, et al. Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe. Eur Respir Rev. 2022;31(166). https:\/\/doi.org\/10.1183\/16000617.0098-2022.","DOI":"10.1183\/16000617.0098-2022"},{"key":"12798_CR7","doi-asserted-by":"publisher","unstructured":"Agwa SHA, Kamel MM, Elghazaly H, et al. Association between interferon-lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 variant polymorphisms with the course and outcome of SARS-CoV-2 patients. Genes (Basel). 2021;12(6). https:\/\/doi.org\/10.3390\/genes12060830.","DOI":"10.3390\/genes12060830"},{"key":"12798_CR8","doi-asserted-by":"publisher","first-page":"145102","DOI":"10.1016\/j.gene.2020.145102","volume":"762","author":"J Gomez","year":"2020","unstructured":"Gomez J, Albaiceta GM, Garcia-Clemente M, et al. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene. 2020;762:145102. https:\/\/doi.org\/10.1016\/j.gene.2020.145102.","journal-title":"Gene"},{"issue":"5","key":"12798_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3855\/jidc.18537","volume":"18","author":"N Ibadullaeva","year":"2024","unstructured":"Ibadullaeva N, Khikmatullaeva A, Mirzaev U, Kan N, Bobkova M, Musabaev E. Identification of CXCL9 chemokine as a potential biomarker for assessing clinical severity in COVID-19 patients. J Infect Dev Ctries. 2024;18(5):672\u20138. https:\/\/doi.org\/10.3855\/jidc.18537.","journal-title":"J Infect Dev Ctries"},{"key":"12798_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7. https:\/\/doi.org\/10.1186\/s13742-015-0047-8.","journal-title":"Gigascience"},{"key":"12798_CR11","unstructured":"Worldometers. 2024. https:\/\/www.worldometers.info\/coronavirus\/country\/uzbekistan\/. Accessed September 30, 2025."},{"issue":"12","key":"12798_CR12","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.21037\/jtd-20-1743","volume":"12","author":"T Zhang","year":"2020","unstructured":"Zhang T, Huang WS, Guan W, et al. Risk factors and predictors associated with the severity of COVID-19 in china: a systematic review, meta-analysis, and meta-regression. J Thorac Dis. 2020;12(12):7429\u201341. https:\/\/doi.org\/10.21037\/jtd-20-1743.","journal-title":"J Thorac Dis"},{"key":"12798_CR13","doi-asserted-by":"publisher","first-page":"o1431","DOI":"10.1136\/bmj.o1431","volume":"377","author":"P Adab","year":"2022","unstructured":"Adab P, Haroon S, O\u2019Hara ME, Jordan RE. Comorbidities and covid-19. BMJ. 2022;377:o1431. https:\/\/doi.org\/10.1136\/bmj.o1431.","journal-title":"BMJ"},{"issue":"8","key":"12798_CR14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s42399-020-00363-4","volume":"2","author":"A Sanyaolu","year":"2020","unstructured":"Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069\u201376. https:\/\/doi.org\/10.1007\/s42399-020-00363-4.","journal-title":"SN Compr Clin Med"},{"issue":"5","key":"12798_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/ajh\/hpaa057","volume":"33","author":"EL Schiffrin","year":"2020","unstructured":"Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. Am J Hypertens. 2020;33(5):373\u20134. https:\/\/doi.org\/10.1093\/ajh\/hpaa057.","journal-title":"Am J Hypertens"},{"key":"12798_CR16","doi-asserted-by":"publisher","unstructured":"Guan WJ, Liang WH, He JX, Zhong NS. Cardiovascular comorbidity and its impact on patients with COVID-19. Eur Respir J. 2020;55(6). https:\/\/doi.org\/10.1183\/13993003.01227-2020.","DOI":"10.1183\/13993003.01227-2020"},{"issue":"6","key":"12798_CR17","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","volume":"31","author":"L Zhu","year":"2020","unstructured":"Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and Pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068\u2013e773. https:\/\/doi.org\/10.1016\/j.cmet.2020.04.021.","journal-title":"Cell Metab"},{"issue":"1","key":"12798_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s12879-021-06536-3","volume":"21","author":"ZG Dessie","year":"2021","unstructured":"Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21(1):855. https:\/\/doi.org\/10.1186\/s12879-021-06536-3.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"12798_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.amjms.2022.01.022","volume":"364","author":"JK Salabei","year":"2022","unstructured":"Salabei JK, Asnake ZT, Ismail ZH, et al. COVID-19 and the cardiovascular system: an update. Am J Med Sci. 2022;364(2):139\u201347. https:\/\/doi.org\/10.1016\/j.amjms.2022.01.022.","journal-title":"Am J Med Sci"},{"issue":"8901","key":"12798_CR20","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s0140-6736(94)92050-8","volume":"343","author":"DG Fogarty","year":"1994","unstructured":"Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC. ACE gene typing. Lancet. 1994;343(8901):851. https:\/\/doi.org\/10.1016\/s0140-6736(94)92050-8.","journal-title":"Lancet"},{"issue":"1","key":"12798_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/8760","volume":"22","author":"MJ Rieder","year":"1999","unstructured":"Rieder MJ, Taylor SL, Clark AG, Nickerson DA. Sequence variation in the human angiotensin converting enzyme. Nat Genet. 1999;22(1):59\u201362. https:\/\/doi.org\/10.1038\/8760.","journal-title":"Nat Genet"},{"issue":"8","key":"12798_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/gb-2003-4-8-225","volume":"4","author":"JF Riordan","year":"2003","unstructured":"Riordan JF. Angiotensin-I-converting enzyme and its relatives. Genome Biol. 2003;4(8):225. https:\/\/doi.org\/10.1186\/gb-2003-4-8-225.","journal-title":"Genome Biol"},{"issue":"2","key":"12798_CR23","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1515\/cclm-2021-1001","volume":"60","author":"JR Delanghe","year":"2022","unstructured":"Delanghe JR, Speeckaert MM, De Buyzere ML. ACE polymorphism is a determinant for COVID-19 mortality in the post-vaccination era. Clin Chem Lab Med. 2022;60(2):e32\u20133. https:\/\/doi.org\/10.1515\/cclm-2021-1001.","journal-title":"Clin Chem Lab Med"},{"key":"12798_CR24","doi-asserted-by":"publisher","first-page":"955965","DOI":"10.3389\/fgene.2022.955965","volume":"13","author":"A Faridzadeh","year":"2022","unstructured":"Faridzadeh A, Mahmoudi M, Ghaffarpour S, et al. The role of ACE1 I\/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study. Front Genet. 2022;13:955965. https:\/\/doi.org\/10.3389\/fgene.2022.955965.","journal-title":"Front Genet"},{"key":"12798_CR25","doi-asserted-by":"publisher","first-page":"201099","DOI":"10.1016\/j.humgen.2022.201099","volume":"34","author":"J Soltani Rezaiezadeh","year":"2022","unstructured":"Soltani Rezaiezadeh J, Lord JS, Yekaninejad MS, Izadi P. The association of ACE I\/D polymorphism with the severity of COVID-19 in Iranian patients: A case-control study. Hum Gene (Amst). 2022;34:201099. https:\/\/doi.org\/10.1016\/j.humgen.2022.201099.","journal-title":"Hum Gene (Amst)"},{"key":"12798_CR26","doi-asserted-by":"publisher","first-page":"798571","DOI":"10.3389\/fmed.2021.798571","volume":"8","author":"H Saad","year":"2021","unstructured":"Saad H, Jabotian K, Sakr C, Mahfouz R, Akl IB, Zgheib NK. The role of angiotensin converting enzyme 1 Insertion\/Deletion genetic polymorphism in the risk and severity of COVID-19 infection. Front Med (Lausanne). 2021;8:798571. https:\/\/doi.org\/10.3389\/fmed.2021.798571.","journal-title":"Front Med (Lausanne)"},{"key":"12798_CR27","doi-asserted-by":"publisher","unstructured":"Aladag E, Tas Z, Ozdemir BS, et al. Human ACE D\/I polymorphism could affect the clinicobiological course of COVID-19. J Renin Angiotensin Aldosterone Syst. 2021;2021:5509280. https:\/\/doi.org\/10.1155\/2021\/5509280.","DOI":"10.1155\/2021\/5509280"},{"key":"12798_CR28","doi-asserted-by":"publisher","first-page":"775246","DOI":"10.3389\/fgene.2022.775246","volume":"13","author":"JLF de Araujo","year":"2022","unstructured":"de Araujo JLF, Menezes D, de Aguiar RS, de Souza RP. IFITM3, FURIN, ACE1, and TNF-alpha genetic association with COVID-19 outcomes: systematic review and Meta-Analysis. Front Genet. 2022;13:775246. https:\/\/doi.org\/10.3389\/fgene.2022.775246.","journal-title":"Front Genet"},{"issue":"4","key":"12798_CR29","doi-asserted-by":"publisher","first-page":"e2323","DOI":"10.1002\/rmv.2323","volume":"32","author":"W Saengsiwaritt","year":"2022","unstructured":"Saengsiwaritt W, Jittikoon J, Chaikledkaew U, Udomsinprasert W. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis. Rev Med Virol. 2022;32(4):e2323. https:\/\/doi.org\/10.1002\/rmv.2323.","journal-title":"Rev Med Virol"},{"issue":"5","key":"12798_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1164\/rccm.2108086","volume":"166","author":"RP Marshall","year":"2002","unstructured":"Marshall RP, Webb S, Bellingan GJ, et al. Angiotensin converting enzyme insertion\/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2002;166(5):646\u201350. https:\/\/doi.org\/10.1164\/rccm.2108086.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"12798_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/gtmb.2020.0207","volume":"25","author":"M Cenanovic","year":"2021","unstructured":"Cenanovic M, Dogan S, Asic A, Besic L, Marjanovic D. Distribution of the ACE1 D allele in the Bosnian-Herzegovinian population and its possible role in the regional epidemiological picture of COVID-19. Genet Test Mol Biomarkers. 2021;25(1):55\u20138. https:\/\/doi.org\/10.1089\/gtmb.2020.0207.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"4","key":"12798_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1017\/S0016672307009019","volume":"89","author":"YB Saab","year":"2007","unstructured":"Saab YB, Gard PR, Overall AD. The geographic distribution of the ACE II genotype: a novel finding. Genet Res. 2007;89(4):259\u201367. https:\/\/doi.org\/10.1017\/S0016672307009019.","journal-title":"Genet Res"},{"key":"12798_CR33","doi-asserted-by":"publisher","first-page":"144944","DOI":"10.1016\/j.gene.2020.144944","volume":"758","author":"N Yamamoto","year":"2020","unstructured":"Yamamoto N, Ariumi Y, Nishida N, et al. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I\/D genotype. Gene. 2020;758:144944. https:\/\/doi.org\/10.1016\/j.gene.2020.144944.","journal-title":"Gene"},{"key":"12798_CR34","doi-asserted-by":"publisher","first-page":"105781","DOI":"10.1016\/j.micpath.2022.105781","volume":"172","author":"M Keikha","year":"2022","unstructured":"Keikha M, Karbalaei M. Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis. Microb Pathog. 2022;172:105781. https:\/\/doi.org\/10.1016\/j.micpath.2022.105781.","journal-title":"Microb Pathog"},{"issue":"7","key":"12798_CR35","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1515\/cclm-2020-0577","volume":"58","author":"M Saadat","year":"2020","unstructured":"Saadat M. No significant correlation between ACE Ins\/Del genetic polymorphism and COVID-19 infection. Clin Chem Lab Med. 2020;58(7):1127\u20138. https:\/\/doi.org\/10.1515\/cclm-2020-0577.","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"12798_CR36","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/ejhg.2011.66","volume":"19","author":"X Li","year":"2011","unstructured":"Li X, Sun X, Jin L, Xue F. Worldwide Spatial genetic structure of angiotensin-converting enzyme gene: a new evolutionary ecological evidence for the thrifty genotype hypothesis. Eur J Hum Genet. 2011;19(9):1002\u20138. https:\/\/doi.org\/10.1038\/ejhg.2011.66.","journal-title":"Eur J Hum Genet"},{"key":"12798_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.38109\/2225-1685-2014-2-63-70","volume":"2","author":"RD Kurbanov","year":"2014","unstructured":"Kurbanov RD, Kurbanov NA, Abdullayev TA. Angiotensin-Converting enzyme gene polymorphism: the clinical course and the structural and functional state of the heart at the Uzbek patients with dilated cardiomyopathy (In Russian). Eurasian Heart J. 2014;2:63\u201370.","journal-title":"Eurasian Heart J"},{"issue":"5","key":"12798_CR38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.physbeh.2010.03.018","volume":"100","author":"AD de Kloet","year":"2010","unstructured":"de Kloet AD, Krause EG, Woods SC. The Renin angiotensin system and the metabolic syndrome. Physiol Behav. 2010;100(5):525\u201334. https:\/\/doi.org\/10.1016\/j.physbeh.2010.03.018.","journal-title":"Physiol Behav"},{"key":"12798_CR39","doi-asserted-by":"publisher","first-page":"146790","DOI":"10.1016\/j.gene.2022.146790","volume":"844","author":"K Gupta","year":"2022","unstructured":"Gupta K, Kaur G, Pathak T, Banerjee I. Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity. Gene. 2022;844:146790. https:\/\/doi.org\/10.1016\/j.gene.2022.146790.","journal-title":"Gene"},{"issue":"7","key":"12798_CR40","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1007\/s10238-023-01038-9","volume":"23","author":"V Pecoraro","year":"2023","unstructured":"Pecoraro V, Cuccorese M, Trenti T. Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNFalpha genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis. Clin Exp Med. 2023;23(7):3251\u201364. https:\/\/doi.org\/10.1007\/s10238-023-01038-9.","journal-title":"Clin Exp Med"},{"issue":"7889","key":"12798_CR41","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","volume":"600","author":"C-HG Initiative","year":"2021","unstructured":"Initiative C-HG. Mapping the human genetic architecture of COVID-19. Nature. 2021;600(7889):472\u20137. https:\/\/doi.org\/10.1038\/s41586-021-03767-x.","journal-title":"Nature"},{"issue":"7921","key":"12798_CR42","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/s41586-022-04826-7","volume":"608","author":"C-HG Initiative","year":"2022","unstructured":"Initiative C-HG. A first update on mapping the human genetic architecture of COVID-19. Nature. 2022;608(7921):E1\u201310. https:\/\/doi.org\/10.1038\/s41586-022-04826-7.","journal-title":"Nature"},{"issue":"7977","key":"12798_CR43","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1038\/s41586-023-06355-3","volume":"621","author":"C-HG Initiative","year":"2023","unstructured":"Initiative C-HG. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023;621(7977):E7\u201326. https:\/\/doi.org\/10.1038\/s41586-023-06355-3.","journal-title":"Nature"},{"issue":"16","key":"12798_CR44","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.jacc.2021.02.055","volume":"77","author":"S Garcia","year":"2021","unstructured":"Garcia S, Dehghani P, Grines C, et al. Initial findings from the North American COVID-19 myocardial infarction registry. J Am Coll Cardiol. 2021;77(16):1994\u20132003. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.055.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"12798_CR45","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/2047487320925965","volume":"27","author":"JS Ho","year":"2020","unstructured":"Ho JS, Tambyah PA, Ho AF, Chan MY, Sia CH. Effect of coronavirus infection on the human heart: A scoping review. Eur J Prev Cardiol. 2020;27(11):1136\u201348. https:\/\/doi.org\/10.1177\/2047487320925965.","journal-title":"Eur J Prev Cardiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12798-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:10:58Z","timestamp":1781633458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12798-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12798"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12798-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5135770\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in accordance with the relevant recommendations and regulations and conducted according to the guidelines of the Declaration of Helsinki. Ethical approval statements for the study were issued by the Ethical Committee of the Ministry of Health of the Republic of Uzbekistan under protocol number 6\/13-1456\/30\/10\/2020. Written informed consent was obtained from all individuals included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"581"}}